Cite
HARVARD Citation
Geoerger, B. et al. (2017). Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma. European journal of cancer. pp. 358-363. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Geoerger, B. et al. (2017). Phase II study of ipilimumab in adolescents with unresectable stage III or IV malignant melanoma. European journal of cancer. pp. 358-363. [Online].